Although the exact pathophysiological contribution of OPG and OPN to peripheral atherosclerotic disease is yet to be elucidated, our findings suggest that OPG and OPN could serve as possible biomarkers of PAD progression/prognosis after endovascular revascularization. The gene discussed is SPP1; the disease is peripheral arterial disease.